A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.
One new story for each specialty, every morning: short, sourced and readable between patients.
None of today's stories are in your chosen specialties. Change specialties or browse all of MedShorts 360.
CardiologyIn 1,012 cardiac surgery patients at a Swedish centre, 43% developed postoperative AF, but documented AF during follow-up was only 8.8% at one year, while oral anticoagulants were often continued, raising concerns about overtreatment.
DiabetologyIn an Italian records study of 80,302 adults with type 2 diabetes, people who stopped GLP-1 receptor agonists had roughly double the rate of nonfatal MI, nonfatal stroke or death compared with matched persistent users.
NephrologyIn a multicentre ICU trial of 554 patients with acute kidney injury, starting with intermittent haemodialysis was not noninferior to continuous renal replacement therapy for 90-day major adverse kidney events, and mortality was higher.
NeurologyLong-term extension data presented at CTAD 2026 showed that continuous lecanemab for five years was linked to slower decline on CDR-SB than in external natural-history cohorts, with ARIA-E becoming uncommon after the first year.
UrologyA European Urology systematic review of 24 studies tied higher waist circumference and BMI to benign prostatic enlargement and bothersome LUTS in Asian men, with lifestyle factors also implicated, though evidence certainty was very low.
PsychiatryA JAMA Network Open economic model found that naltrexone for 16 weeks plus a year of counselling, started at F3 fibrosis in alcohol-associated liver disease, cut liver deaths and cirrhosis and lowered lifetime costs versus no treatment.
PulmonologyIn an AJRCCM cohort of 2,779 non-diabetic adults with obesity-associated moderate-to-severe asthma, tirzepatide starters had a lower hazard of severe exacerbation than tezepelumab starters, while semaglutide performed similarly.
Critical CareA CENTER-TBI target trial emulation of 773 adults with severe traumatic brain injury found that treatment at centres more inclined to use ICP-guided management was associated with lower ICU mortality, most clearly when one or both pupils were unreactive.
GastroenterologyIn 3,122 Chinese patients with large-artery stroke on aspirin plus clopidogrel or ticagrelor, GI bleeding was 2.1% with a PPI and 1.3% without (adjusted OR 1.51, 95% CI 0.87-2.62), showing no clear protective effect.
DermatologyIn 26 Spanish adults with chronic prurigo nodularis, 59% of evaluable patients had a 4-point or greater itch reduction at week 24; five of nine patients who extended dosing intervals stayed clear or almost clear.
OphthalmologyIn a matched TriNetX analysis of 2,605 diabetic adults on systemic IL-6 inhibitors versus controls, users had lower 5-year risks of NPDR, PDR (53% lower) and DME (63% lower); the authors say prospective trials are needed.
ENTAmong 10,254 newborns and infants screened with OAE at a Davangere teaching hospital over 4.5 years, 241 needed BERA and 42 had abnormal results, giving a deafness incidence of 4.095 per 1,000 screened.
OrthopaedicsIn 83 adults with open long-bone fractures in eastern India, deep infection was numerically lowest with early debridement plus pulsatile lavage, but no primary outcome differed significantly; the authors call the results hypothesis-generating.
GynaecologyACOG's updated guidance says tubes should routinely be removed at hysterectomy, offered at other peritoneal gynaecological surgery when fertility is not wanted, and preferred for permanent contraception.
PaediatricsIn Danish national test data, children with a history of febrile seizures scored almost the same as peers; lower scores were seen mainly with many seizure-related hospital contacts or later epilepsy.
SurgeryIn 262 adults with type 2 diabetes, 58% assigned to metabolic-bariatric surgery were in remission at long-term follow-up versus 3% with intensive medical and lifestyle management.
General MedicineIn a Dutch double-blind trial of 44 adults with new idiopathic inflammatory myopathy, IVIG plus prednisone gave major improvement at 12 weeks in 70% versus 26% with placebo plus prednisone.
Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.
Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.
MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.
The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.
Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.
Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.
Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.
Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.
When all three roles learn from the same source, the patient hears one consistent story about their treatment.
Learns the evidence, passes certification, shares an approved MedShorts link.
Reviews the update in minutes, prescribes with the latest guidance, shares patient material.
Dispenses correctly and counsels on dose, timing, side-effects and adherence.
Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.
Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.
Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.
Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.
Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.
Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.
A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.
One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.
Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.
Apply it in practice, share patient material, or continue to a full CME course.
Engagement flows into the brand dashboard and shapes the next content cycle.
Two-to-three-minute reads on a single clinical question.
Expert perspectives in three-to-five-minute clips.
Landmark and recent trials summarised with key numbers.
What changed, and what it means in clinic.
Test and reinforce, with instant explanations.
Leaflets and videos doctors and pharmacists can share.
Lung-sound and ECG trainers, calculators and checklists.
Interaction, storage and pharmacovigilance reminders.
MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.
The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.
Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.